Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nutr Clin Pract. 2010 Apr;25(2):143-59. doi: 10.1177/0884533610362239.

Pharmacotherapy of eating disorders.

Author information

  • 1University of Alabama, Birmingham, AL 35294-0018, USA. cwj0002@auburn.edu

Abstract

Eating disorders are complex, chronic disorders that are difficult to treat. In addition, the 2 primary eating disorders, anorexia nervosa and bulimia nervosa, may have acute, life-threatening consequences. Medication trials for eating disorders have been hampered by high dropout rates, high placebo response, short trial duration, insufficient doses, and difficult outcome measures. Only 1 medication has been FDA approved for any eating disorder to date, and that is for fluoxetine in the treatment of bulimia. Clearly, new large-scale, independent studies using novel agents, and studying the use of medications for both short- and long-term outcomes, are needed.

PMID:
20413695
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk